We are excited to welcome Steve to Phathom during this important growth period for our Company,” said Michael Cola, Chairman of Phathom. “Steve is an accomplished biopharmaceutical leader with a ...
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...
ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to ...
Weleda has unveiled a rebrand with a new logo and updated modern look. It is the first update to the design of the Swiss natural brand in its 100-year history. “Our brand identity is now more modern, ...
Graphic: Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year. Used with ...
ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord ...
Gen Z men's experimentation with skin care brands, deodorants' fine fragrance glow up, and Amazon's category domination are ...
Pragmatic NFC Connect product innovation expands market opportunities for edge and item-level intelligence at scale Industry-leading low carbon footprint, optimised designUltra-thin and ...
The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.
Rebranding efforts include a new logo, overall brand presence, and corporate design.